BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33737712)

  • 21. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
    Ikeda K; Hayakawa K; Fujishiro M; Kawasaki M; Hirai T; Tsushima H; Miyashita T; Suzuki S; Morimoto S; Tamura N; Takamori K; Ogawa H; Sekigawa I
    BMC Immunol; 2017 Aug; 18(1):41. PubMed ID: 28830352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis.
    Jager LD; Dabelic R; Waiboci LW; Lau K; Haider MS; Ahmed CM; Larkin J; David S; Johnson HM
    J Neuroimmunol; 2011 Mar; 232(1-2):108-18. PubMed ID: 21131060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice.
    Hecht M; Müller M; Lohmann-Matthes ML; Emmendörffer A
    J Leukoc Biol; 1995 Feb; 57(2):242-9. PubMed ID: 7852838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
    Fan X; Wüthrich RP
    Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS1-KIR Peptide in PEGDA Hydrogels Reduces Pro-Inflammatory Macrophage Activation.
    Jha A; Larkin J; Moore E
    Macromol Biosci; 2023 Sep; 23(9):e2300237. PubMed ID: 37337867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice.
    Huang X; Xie Z; Liu F; Han C; Zhang D; Wang D; Bao X; Sun J; Wen C; Fan Y
    Int Immunopharmacol; 2014 Sep; 22(1):266-72. PubMed ID: 25027631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.
    Qu WM; Miyazaki T; Terada M; Okada K; Mori S; Kanno H; Nose M
    Clin Exp Immunol; 2002 Jul; 129(1):27-34. PubMed ID: 12100019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.
    Zhan Y; Davey GM; Graham KL; Kiu H; Dudek NL; Kay T; Lew AM
    Immunol Cell Biol; 2009; 87(6):473-80. PubMed ID: 19381159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
    Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
    J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
    Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
    PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).
    Sugiyama N; Nakashima H; Yoshimura T; Sadanaga A; Shimizu S; Masutani K; Igawa T; Akahoshi M; Miyake K; Takeda A; Yoshimura A; Hamano S; Yoshida H
    Ann Rheum Dis; 2008 Oct; 67(10):1461-7. PubMed ID: 18094002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.